Angle (AGL) RNS Announcements

Add to Alert list
Date Time Source Announcement
02 Jul 2021 10:45 AM
RNS
Issue of Equity
30 Jun 2021 03:44 PM
RNS
Result of AGM
25 Jun 2021 07:00 AM
RNS
Result of Accelerated Bookbuild
24 Jun 2021 06:28 PM
RNS
Accelerated bookbuild to raise up to £20m
18 Jun 2021 11:42 AM
RNS
Annual General Meeting update
18 Jun 2021 07:00 AM
RNS
ctDNA and CTCs have differences in EGFR mutations
04 Jun 2021 07:00 AM
RNS
Update on submission for FDA clearance
01 Jun 2021 07:00 AM
RNS
Potential to prevent breast cancer relapse
20 May 2021 07:00 AM
RNS
Parsortix demonstrates oesophageal cancer utility
19 May 2021 04:37 PM
RNS
Exercise of options and total voting rights
11 May 2021 07:00 AM
RNS
Parsortix study uncovers targets in TNBC patients
30 Apr 2021 11:22 AM
RNS
Exercise of options and total voting rights
29 Apr 2021 07:00 AM
RNS
Preliminary Results
26 Apr 2021 07:00 AM
RNS
Ovarian cancer study patient enrolment completed
19 Apr 2021 02:05 PM
RNS
Second Price Monitoring Extn
19 Apr 2021 02:00 PM
RNS
Price Monitoring Extension
19 Apr 2021 11:05 AM
RNS
Second Price Monitoring Extn
19 Apr 2021 11:00 AM
RNS
Price Monitoring Extension
16 Apr 2021 07:00 AM
RNS
First large-scale pharma services contract secured
15 Apr 2021 04:10 PM
RNS
Notice of Preliminary Results and Webcast
12 Apr 2021 07:00 AM
RNS
ANGLE's Parsortix system showcased at AACR 2021
30 Mar 2021 07:00 AM
RNS
Global launch of clinical services laboratories
04 Mar 2021 07:00 AM
RNS
Update on submission for FDA clearance
18 Feb 2021 07:00 AM
RNS
Parsortix-harvested CTCs uncover novel biomarker
08 Feb 2021 07:00 AM
RNS
Parsortix: Dynamic assessment of patient response
29 Jan 2021 07:00 AM
RNS
Parsortix demonstrates high capture rate of CTCs
26 Jan 2021 01:00 PM
RNS
Holding(s) in Company
20 Jan 2021 07:00 AM
RNS
Research confirms high performance of Parsortix
12 Jan 2021 07:00 AM
RNS
Change of Auditor
05 Jan 2021 07:00 AM
RNS
Issue of Equity
09 Dec 2020 07:00 AM
RNS
Parsortix can capture single cancer cell in sample
20 Nov 2020 04:18 PM
RNS
Holding(s) in Company
18 Nov 2020 04:51 PM
RNS
Holding(s) in Company
13 Nov 2020 10:46 AM
RNS
Result of General Meeting
03 Nov 2020 02:54 PM
RNS
Director/PDMR Shareholding
29 Oct 2020 07:00 AM
RNS
Interim Results
27 Oct 2020 06:28 PM
RNS
Result of Placing & Notice of General Meeting
27 Oct 2020 07:00 AM
RNS
Accelerated bookbuild to raise up to £20m
20 Oct 2020 07:00 AM
RNS
Submission accepted by FDA for substantive review
28 Sep 2020 07:00 AM
RNS
Issue of LTIP Options and Share Options
28 Sep 2020 07:00 AM
RNS
ANGLE announces completion of FDA submission
23 Sep 2020 07:00 AM
RNS
Potential treatment strategy to limit metastasis
11 Sep 2020 03:35 PM
RNS
Holding(s) in Company
11 Sep 2020 03:30 PM
RNS
Holding(s) in Company
02 Sep 2020 01:49 PM
RNS
Notification of Interim Results and Webcast
02 Sep 2020 10:00 AM
RNS
Holding(s) in Company
27 Aug 2020 03:13 PM
RNS
Result of 2020 Annual General Meeting
18 Aug 2020 09:30 AM
RNS
Holding(s) in Company
14 Aug 2020 07:00 AM
RNS
Parsortix use to assess response to immunotherapy
06 Aug 2020 12:20 PM
RNS
Holding(s) in Company

ANGLE PLC is a commercially driven specialist medical diagnostic company with pioneering products in cancer diagnostics and foetal health. The Company's product includes Parsortix cell separation system.

Founded in 1994, AGL share price listed on LSE in 2004 under the ticker AGL.

UK 100